Resultados de la búsqueda 161-170 of 13939 for Hepatic encephalopathy
Page 1.
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...
Rochester, Minn. The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these ...
A Mayo Clinic collaboration studies engineered stem cells for liver disease · Mayo Clinic researchers develop AI-ECG model to diagnose liver disease earlier ...
The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...
The purpose of this study is to evaluate a low-cost Contrast Enhanced Digital Mammogram (CEDM) protocol as a supplemental screening method to standard ...
The purpose of this study is to evaluate changes in CSF dynamics (e.g., velocity, flow rate) between patients with normal pressure hydrocephalus and healthy ...
Biliary atresia is a rare liver condition that affects newborns and infants. It occurs when the bile ducts become inflamed and blocked or fail to form correctly ...
Kalas MA, et al. Abnormal liver enzymes: A review for clinicians. World Journal of Hepatology. 2021; doi:10.4254/wjh.v13.i11.1688. Burt A, et al., eds. Liver in ...
Hepatic encephalopathy. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/hepatic-encephalopathy/symptoms-causes/syc-20583828. Accessed Feb. 8 ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?